Nicholas E Hagemeier1, Fred Tudiver2, Scott Brewster3, Elizabeth J Hagy3, Angela Hagaman4, Robert P Pack5. 1. Department of Pharmacy Practice, East Tennessee State University Gatton College of Pharmacy, P.O. Box 70657, Johnson City, TN 37614, USA. Electronic address: hagemeier@etsu.edu. 2. Department of Family Medicine, East Tennessee State University Quillen College of Medicine, USA. 3. East Tennessee State University Gatton College of Pharmacy, USA. 4. East Tennessee State University College of Public Health, USA. 5. Department of Community and Behavioral Health, East Tennessee State University College of Public Health, USA.
Abstract
BACKGROUND: Interpersonal communication is inherent in a majority of strategies seeking to engage prescriber and pharmacist health care professionals (HCPs) in the reduction and prevention of prescription drug abuse (PDA). However, research on HCP PDA communication behavioral engagement and factors that influence it is limited. OBJECTIVES: This study quantitatively examined communication behaviors and trait-level communication metrics, and qualitatively described prescription drug abuse-related communication perceptions and behaviors among primary care prescribers and community pharmacists. METHODS: Five focus groups (N = 35) were conducted within the Appalachian Research Network (AppNET), a rural primary care practice-based research network (PBRN) in South Central Appalachia between February and October, 2014. Focus groups were structured around the administration of three previously validated trait-level communication survey instruments, and one instrument developed by the investigators to gauge HCP prescription drug abuse communication engagement and perceived communication importance. Using a grounded theory approach, focus group themes were inductively derived and coded independently by study investigators. Member-checking interviews were conducted to validate derived themes. RESULTS: Respondents' trait-level communication self-perceptions indicated low communication apprehension, high self-perceived communication competence, and average willingness to communicate as compared to instrument specific criteria and norms. Significant variation in HCP communication behavior engagement was noted specific to PDA. Two overarching themes were noted for HCP-patient communication: 1) influencers of HCP communication and prescribing/dispensing behaviors, and 2) communication behaviors. Multiple sub-themes were identified within each theme. Similarities were noted in perceptions and behaviors across both prescribers and pharmacists. CONCLUSIONS: Despite the perceived importance of engaging in PDA communication, HCPs reported that prescription drug abuse communication is uncomfortable, variable, multifactorial, and often avoided. The themes that emerged from this analysis support the utility of communication science and health behavior theories to better understand and improve PDA communication behaviors of both prescribers and pharmacists, and thereby improve engagement in PDA prevention and treatment.
BACKGROUND: Interpersonal communication is inherent in a majority of strategies seeking to engage prescriber and pharmacist health care professionals (HCPs) in the reduction and prevention of prescription drug abuse (PDA). However, research on HCP PDA communication behavioral engagement and factors that influence it is limited. OBJECTIVES: This study quantitatively examined communication behaviors and trait-level communication metrics, and qualitatively described prescription drug abuse-related communication perceptions and behaviors among primary care prescribers and community pharmacists. METHODS: Five focus groups (N = 35) were conducted within the Appalachian Research Network (AppNET), a rural primary care practice-based research network (PBRN) in South Central Appalachia between February and October, 2014. Focus groups were structured around the administration of three previously validated trait-level communication survey instruments, and one instrument developed by the investigators to gauge HCP prescription drug abuse communication engagement and perceived communication importance. Using a grounded theory approach, focus group themes were inductively derived and coded independently by study investigators. Member-checking interviews were conducted to validate derived themes. RESULTS: Respondents' trait-level communication self-perceptions indicated low communication apprehension, high self-perceived communication competence, and average willingness to communicate as compared to instrument specific criteria and norms. Significant variation in HCP communication behavior engagement was noted specific to PDA. Two overarching themes were noted for HCP-patient communication: 1) influencers of HCP communication and prescribing/dispensing behaviors, and 2) communication behaviors. Multiple sub-themes were identified within each theme. Similarities were noted in perceptions and behaviors across both prescribers and pharmacists. CONCLUSIONS: Despite the perceived importance of engaging in PDA communication, HCPs reported that prescription drug abuse communication is uncomfortable, variable, multifactorial, and often avoided. The themes that emerged from this analysis support the utility of communication science and health behavior theories to better understand and improve PDA communication behaviors of both prescribers and pharmacists, and thereby improve engagement in PDA prevention and treatment.
Authors: Catherine S Hwang; Lydia W Turner; Stefan P Kruszewski; Andrew Kolodny; G Caleb Alexander Journal: JAMA Intern Med Date: 2015-02 Impact factor: 21.873
Authors: Catherine S Hwang; Lydia W Turner; Stefan P Kruszewski; Andrew Kolodny; G Caleb Alexander Journal: Clin J Pain Date: 2016-04 Impact factor: 3.442
Authors: Marc L Fleming; Jamie C Barner; Carolyn M Brown; Marv D Shepherd; Scott A Strassels; Suzanne Novak Journal: J Am Pharm Assoc (2003) Date: 2014 May-Jun
Authors: Marc L Fleming; Jamie C Barner; Carolyn M Brown; Marvin D Shepherd; Scott Strassels; Suzanne Novak Journal: Res Social Adm Pharm Date: 2013-06-29
Authors: Aaron Salwan; Nicholas E Hagemeier; Fred Tudiver; KariLynn Dowling-McClay; Kelly N Foster; Jessie Arnold; Arsham Alamian; Robert P Pack Journal: J Am Pharm Assoc (2003) Date: 2020-07-12
Authors: Nicholas E Hagemeier; Fred Tudiver; Scott Brewster; Elizabeth J Hagy; Brittany Ratliff; Angela Hagaman; Robert P Pack Journal: Subst Abus Date: 2017-09-15 Impact factor: 3.716
Authors: Daniel M Hartung; Jennifer Hall; Sarah N Haverly; David Cameron; Lindsey Alley; Christi Hildebran; Nicole O'Kane; Deborah Cohen Journal: Pain Med Date: 2018-09-01 Impact factor: 3.750